Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach dose of Mounjaro delivers 0.5 ml of solution, regardless of which strength you are taking. Whether your pen is 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg or 15 mg, the volume injected is always the same half-millilitre — the dose and the volume are two different things, and that distinction trips up a lot of people. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses suitability and determines the right strength for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is whether a higher-strength pen delivers more liquid. It does not. Eli Lilly designed each KwikPen so that the injection volume stays fixed at 0.5 ml from the 2.5 mg starter right through to the 15 mg maintenance dose. What changes is the concentration of tirzepatide dissolved in that 0.5 ml, more milligrams of active medicine packed into the same small volume of solution.
This matters practically. A patient moving from 5 mg to 7.5 mg will not feel a larger injection; the sensation at the site stays broadly the same. The pen's internal geometry changes between strengths, but the plunger travel and the amount of fluid entering the tissue remain constant. If you have ever held two different-strength pens side by side and thought they looked identical, that is why.
For a plain-language breakdown of how volume relates to concentration across the UK strength range, our guide to how many ml are in a dose of Mounjaro goes into the numbers in detail, and our page on Mounjaro ml per dose is a useful companion if you want to see exactly how each strength's concentration is calculated. The NHS also publishes accessible patient information on tirzepatide, the NHS tirzepatide page is a reliable first stop for general questions about how the medicine works.
No. The KwikPen is a pre-filled, single-use device, the dose is set at the factory. You do not draw up liquid, read a syringe barrel or make any volume calculation before or during injection. Pressing the button and holding it in delivers the full 0.5 ml automatically.
What you do control is the number of clicks during priming (when setting up a new pen for the first time) and confirming that the dose window shows the correct indicator after injection. If you are curious about how the click count maps to delivery, our detailed page on how many clicks make up a Mounjaro dose explains the mechanism step by step.
One practical note: the pen contains four weekly doses, each 0.5 ml, totalling 2 ml of solution in the cartridge. Seeing liquid remaining in the pen after your dose is entirely normal, that is the next week's supply, not a missed dose. Always follow the Patient Information Leaflet that comes with your pen for precise instructions; the prescriber's guidance and the leaflet together are your definitive reference, not any third-party measurement.
Half a millilitre is a small volume for a subcutaneous injection, which is part of why tolerability is generally reasonable for most people. The medicine goes into the fatty tissue just beneath the skin (abdomen, outer thigh or upper arm) and the volume is well within the range that subcutaneous tissue handles comfortably.
Rotating the injection site each week matters more than the volume itself. Using the same spot repeatedly can cause lipohypertrophy (a thickening under the skin) that slows absorption. The Mounjaro treatment overview covers injection technique alongside everything else you would want to know before starting.
Some people wonder whether a different concentration of 0.5 ml (say, the 5 mg strength rather than 2.5 mg) feels different to inject. For a closer look at how the two lowest strengths compare from a clinical standpoint, the page exploring whether 5 mg Mounjaro is meaningfully different from 2.5 mg addresses that question directly. Strength decisions always rest with the prescriber reviewing your progress.
Knowing that each pen holds 2 ml total (four doses of 0.5 ml) is useful context for storage. The pen must be kept refrigerated between 2°C and 8°C; once in use, the Patient Information Leaflet specifies the room-temperature window, always check the leaflet rather than relying on general guidance, because storage rules are strength-specific and can change with product updates.
From a supply perspective, the 0.5 ml dose volume is also why pen shortages affect all strengths equally, it is not that a higher-strength pen is harder to fill. If you are thinking about the cost side of treatment, our Mounjaro price comparison page covers what UK private prescriptions typically cost and what legitimate pricing includes. Supply and cost questions are worth raising at the free consultation, where a prescriber can also advise on the most appropriate strength given your current point in treatment.
Mounjaro's volume consistency across strengths is one of the quieter design choices that makes the pen straightforward to use. The medicine is licensed by the MHRA and the full prescribing detail (including exact storage windows and the complete list of ingredients in that 0.5 ml solution) is published on the electronic Medicines Compendium (eMC), where the Mounjaro Summary of Product Characteristics is freely available.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.